Logo


Podcast: what makes coronavirus medicine by cipla

Podcast: what makes coronavirus medicine by cipla

Equity market ended on a positive note on Monday as Drugs Controller General of India's (DCGI) approval to select pharma companies to manufacture and market "potential" Covid-19 drugs lifted investor sentiment, resulting in broad-based buying. Glenmark Pharmaceuticals was the stock of the day as the scrip ended 27 per cent higher at Rs 520 on the BSE after the company said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19. The stock hit a 52-week high of Rs 572.70 during the ...